Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/185521
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peremiquel Trillas, Paula | - |
dc.contributor.author | Saura Lázaro, Anna | - |
dc.contributor.author | Benavente Moreno, Yolanda | - |
dc.contributor.author | Casabonne, Delphine | - |
dc.contributor.author | Loureiro, Eva | - |
dc.contributor.author | Cabrera Jaime, Sandra | - |
dc.contributor.author | Duran, Angela | - |
dc.contributor.author | Garrote, Lidia | - |
dc.contributor.author | Brao, Immaculada | - |
dc.contributor.author | Trelis, Jordi | - |
dc.contributor.author | Galán, Maica | - |
dc.contributor.author | Soler, Francesc | - |
dc.contributor.author | Julià, Joaquim | - |
dc.contributor.author | Cortasa, Dolça | - |
dc.contributor.author | Domínguez Luzón, Ma. Ángeles (María Ángeles) | - |
dc.contributor.author | Albasanz Puig, Adaia | - |
dc.contributor.author | Gudiol, Carlota | - |
dc.contributor.author | Ramírez Tarruella, Dolors | - |
dc.contributor.author | Muniesa, Joan | - |
dc.contributor.author | Rivas, Juan Pedro | - |
dc.contributor.author | Muñoz Montplet, Carles | - |
dc.contributor.author | Sedano, Ana | - |
dc.contributor.author | Plans, Àngel | - |
dc.contributor.author | Calvo Cerrada, Beatriz | - |
dc.contributor.author | Calle, Candela | - |
dc.contributor.author | Clopés Estela, Ana | - |
dc.contributor.author | Carnicer Pont, Dolors | - |
dc.contributor.author | Alemany, Laia | - |
dc.contributor.author | Fernández Muñoz, Esteve | - |
dc.date.accessioned | 2022-05-13T08:03:41Z | - |
dc.date.available | 2022-05-13T08:03:41Z | - |
dc.date.issued | 2022-04-01 | - |
dc.identifier.uri | http://hdl.handle.net/2445/185521 | - |
dc.description.abstract | Objectives Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. Design Cross-sectional study (21 May 2020-26 June 2020). Setting A comprehensive cancer centre (Institut Catala d'Oncologia) in Catalonia, Spain. Participants All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. Primary outcome measure Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. Results A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25-p75: 34.8-51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). Conclusions At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Catala d'Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BMJ | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-056637 | - |
dc.relation.ispartof | BMJ Open, 2022, vol. 12, num. 4, p. e056637 | - |
dc.relation.uri | https://doi.org/10.1136/bmjopen-2021-056637 | - |
dc.rights | cc by (c) Peremiquel Trillas, Paula et al., 2022 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Pandèmia de COVID-19, 2020- | - |
dc.subject.classification | SARS-CoV-2 | - |
dc.subject.classification | Hospitals | - |
dc.subject.other | COVID-19 Pandemic, 2020- | - |
dc.subject.other | SARS-CoV-2 | - |
dc.subject.other | Hospitals | - |
dc.title | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 730475 | - |
dc.date.updated | 2022-05-12T10:10:11Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 35450905 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
e056637.full.pdf | 754.69 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License